• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 FIB-4 和瞬时弹性成像在评估社区慢性丙型肝炎患者肝纤维化中的作用。

Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Public Health Bureau, Tainan City Government, Tainan, Taiwan.

出版信息

PLoS One. 2018 Nov 7;13(11):e0206947. doi: 10.1371/journal.pone.0206947. eCollection 2018.

DOI:10.1371/journal.pone.0206947
PMID:30403744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6221348/
Abstract

BACKGROUND AND AIM

The role of non-invasive methods to evaluate fibrosis severity of chronic hepatitis C (CHC) subjects in community needs to be explored. This study investigated FIB-4 and transient elastography (TE) in staging liver fibrosis of CHC subjects in community.

METHODS

A total of 905 subjects who were positive for anti-HCV antibody from five districts of Tainan City of Taiwan were invited to participate in surveillance activities for CHC. FIB-4 and TE were measured for each participant.

RESULTS

A total of 502 subjects with detectable HCV RNA and valid TE were enrolled. The distribution of FIB-4 and TE values differed markedly. Both methods exhibited a strongest correlation in subjects with at age 50~60 years (r = 0.655, p <0.001). FIB-4 score increased proportionally with age (p <0.001), but TE did not (p = 0.142). The intraclass correlation efficient of both methods was 0.255 (p <0.001). Subjects with TE defined advanced fibrosis exhibited younger age, higher BMI, higher platelet count, lower FIB-4 score, higher incidence of fatty liver and splenomegaly, and higher controlled attenuation parameter value than those defined by FIB-4. By multivariate logistic regression analysis, higher ALT levels, higher incidence of fatty liver, and presence of splenomegaly were the independent factors associated with advanced fibrosis defined by TE rather than defined by FIB-4.

CONCLUSIONS

FIB-4 and TE defined different distribution of fibrosis stages in same HCV population. FIB-4 was deeply influenced by age whereas TE was not. TE had the advantages over than FIB-4 in strong association with splenomegaly and in detecting the role of non-alcoholic fatty liver disease in advanced fibrosis.

摘要

背景与目的

需要探索非侵入性方法在社区中评估慢性丙型肝炎(CHC)患者纤维化严重程度的作用。本研究调查了 FIB-4 和瞬时弹性成像(TE)在社区 CHC 患者肝纤维化分期中的作用。

方法

共邀请了台湾台南市五个区的 905 名抗 HCV 抗体阳性者参加 CHC 监测活动。对每位参与者进行了 FIB-4 和 TE 测量。

结果

共纳入了 502 名可检测到 HCV RNA 和有效 TE 的患者。FIB-4 和 TE 值的分布差异明显。两种方法在年龄为 50~60 岁的患者中相关性最强(r = 0.655,p <0.001)。FIB-4 评分随年龄呈比例增加(p <0.001),但 TE 则没有(p = 0.142)。两种方法的组内相关系数为 0.255(p <0.001)。TE 定义的晚期纤维化患者比 FIB-4 定义的晚期纤维化患者年龄更小、BMI 更高、血小板计数更高、FIB-4 评分更低、脂肪肝和脾肿大的发生率更高、受控衰减参数值更高。通过多变量逻辑回归分析,较高的 ALT 水平、较高的脂肪肝发生率和脾肿大的存在是与 TE 定义的而不是 FIB-4 定义的晚期纤维化相关的独立因素。

结论

FIB-4 和 TE 在同一 HCV 人群中定义了不同的纤维化分期分布。FIB-4 受年龄影响较大,而 TE 则不受影响。TE 在与脾肿大强烈相关以及在检测非酒精性脂肪性肝病在晚期纤维化中的作用方面优于 FIB-4。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fa/6221348/5e32b0b299c4/pone.0206947.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fa/6221348/ce435e1ab39f/pone.0206947.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fa/6221348/5e32b0b299c4/pone.0206947.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fa/6221348/ce435e1ab39f/pone.0206947.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04fa/6221348/5e32b0b299c4/pone.0206947.g002.jpg

相似文献

1
Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community.比较 FIB-4 和瞬时弹性成像在评估社区慢性丙型肝炎患者肝纤维化中的作用。
PLoS One. 2018 Nov 7;13(11):e0206947. doi: 10.1371/journal.pone.0206947. eCollection 2018.
2
Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.直接抗病毒药物治疗慢性丙型肝炎可导致瞬时弹性成像和纤维化标志物 4 分(fibrosis-4 score)及天冬氨酸氨基转移酶-血小板比值指数(aspartate aminotransferase-platelet ratio index)迅速改善。
Liver Int. 2017 Mar;37(3):369-376. doi: 10.1111/liv.13256. Epub 2016 Nov 3.
3
The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.非侵入性方法在慢性丙型肝炎血液透析患者肝纤维化评估中的适用性
PLoS One. 2020 Nov 20;15(11):e0242601. doi: 10.1371/journal.pone.0242601. eCollection 2020.
4
Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.瞬时弹性成像与 APRI 和 FIB-4 在先天性出血性疾病伴 HCV 或 HIV/HCV 合并感染患者队列中的相关性。
Haemophilia. 2010 Sep 1;16(5):778-85. doi: 10.1111/j.1365-2516.2010.02204.x. Epub 2010 Mar 15.
5
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.瞬时弹性成像技术用于检测非酒精性脂肪性肝病和慢性病毒性肝炎纤维化的可靠性。
J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.
6
COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.COMP血清水平:慢性病毒性肝炎患者肝纤维化的一种新型非侵入性生物标志物。
Eur J Intern Med. 2017 Mar;38:83-88. doi: 10.1016/j.ejim.2017.01.007. Epub 2017 Jan 15.
7
Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.肝纤维化 4 指数高于低截断指数的非酒精性脂肪性肝病患者的肝硬度分布。
J Gastroenterol Hepatol. 2019 Aug;34(8):1411-1416. doi: 10.1111/jgh.14559. Epub 2019 Jan 6.
8
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.在慢性丙型肝炎患者中,基于四个因素的纤维化指数比天冬氨酸转氨酶/血小板比率指数能更好地预测进展性肝纤维化或肝硬化。
J Formos Med Assoc. 2015 Oct;114(10):923-8. doi: 10.1016/j.jfma.2015.07.004. Epub 2015 Aug 13.
9
Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.慢性乙型和丙型肝炎患者肝纤维化无创诊断评估的比较
Scand J Gastroenterol. 2011 Jul;46(7-8):962-72. doi: 10.3109/00365521.2011.574725. Epub 2011 May 30.
10
Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.慢性丙型肝炎病毒患者肝纤维化分期中弹性成像点定量与其他非侵入性检查方法准确性的评估
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):882-887. doi: 10.1097/MEG.0000000000001151.

引用本文的文献

1
Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease.炎症性肠病患者的肝脏纤维化指数-4与肝脏弹性成像不相关。
J Clin Med. 2024 Oct 27;13(21):6430. doi: 10.3390/jcm13216430.
2
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.一般人群中临床显著肝纤维化的患病率:系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30.
3
Diagnosis of esophageal varices by liver stiffness and serum biomarkers in virus-related compensated advanced chronic liver disease.

本文引用的文献

1
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.在基层医疗环境中进行肝脏硬度测量可检测到高比例的晚期纤维化,并预测丙型肝炎相关的肝脏事件。
J Hepatol. 2018 Sep;69(3):575-583. doi: 10.1016/j.jhep.2018.04.013. Epub 2018 Apr 28.
2
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.振动控制瞬时弹性成像评估非酒精性脂肪性肝病患者的纤维化和脂肪变性。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26.
3
通过肝脏硬度和血清生物标志物诊断病毒相关性代偿期晚期慢性肝病中的食管静脉曲张
Can Liver J. 2023 Oct 30;6(3):332-346. doi: 10.3138/canlivj-2022-0047. eCollection 2023 Oct.
4
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review.瞬时弹性成像技术无创评估肝纤维化:一项叙述性综述。
Viruses. 2023 Aug 13;15(8):1730. doi: 10.3390/v15081730.
5
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients.通过瞬时弹性成像对慢性丙型肝炎患者进行肝脏硬度的纵向评估。
World J Clin Cases. 2022 Jun 16;10(17):5566-5576. doi: 10.12998/wjcc.v10.i17.5566.
6
Role of Lymphotoxin-α Gene Polymorphism in Hepatitis C Virus-Related Chronic Liver Disorders.淋巴毒素-α基因多态性在丙型肝炎病毒相关慢性肝脏疾病中的作用
Infect Drug Resist. 2021 May 25;14:1921-1930. doi: 10.2147/IDR.S306879. eCollection 2021.
7
Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment.真实世界中单中心经验:直接作用抗病毒药物改善慢性丙型肝炎治疗后的肝纤维化。
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620974835. doi: 10.1177/2040206620974835.
8
Non-invasive tests for the prediction of primary hepatocellular carcinoma.用于预测原发性肝细胞癌的非侵入性检测方法。
World J Gastroenterol. 2020 Jun 28;26(24):3326-3343. doi: 10.3748/wjg.v26.i24.3326.
9
Advances in non-invasive assessment of hepatic fibrosis.肝纤维化无创评估的进展。
Gut. 2020 Jul;69(7):1343-1352. doi: 10.1136/gutjnl-2018-317593. Epub 2020 Feb 17.
10
Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases.慢性肝病患者握力与m2bpgi之间存在显著相关性。
J Clin Med. 2019 Sep 1;8(9):1359. doi: 10.3390/jcm8091359.
EASL Recommendations on Treatment of Hepatitis C 2018.
2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
4
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.控制衰减参数对肝硬度测量检测纤维化的影响。
Aliment Pharmacol Ther. 2018 Apr;47(7):989-1000. doi: 10.1111/apt.14529. Epub 2018 Feb 15.
5
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials.在未患有肝硬化且感染 HCV 基因 1、2 或 3 型的参与者中,与格拉瑞韦/艾尔巴韦/奥比他韦相比,格拉瑞韦/鲁索那韦/乌帕司他韦 8 周疗程的安全性和疗效(C-CREST-1 和 C-CREST-2,A 部分):两项随机、2 期、开放性标签试验。
Lancet Gastroenterol Hepatol. 2017 Nov;2(11):805-813. doi: 10.1016/S2468-1253(17)30159-0. Epub 2017 Aug 10.
6
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.对于初治的基因1型丙型肝炎感染患者,8周或12周的来迪派韦和索磷布韦治疗方案的有效性。
Aliment Pharmacol Ther. 2017 Sep;46(5):540-548. doi: 10.1111/apt.14204. Epub 2017 Jul 10.
7
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.丙型肝炎肝硬化患者获得持续病毒学应答后的生存率与普通人群相似。
J Hepatol. 2016 Jun;64(6):1217-23. doi: 10.1016/j.jhep.2016.01.034. Epub 2016 Apr 5.
8
The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.通过社区筛查项目对无明显肝脏疾病居民进行肝脏硬度测量的应用
Medicine (Baltimore). 2016 Mar;95(12):e3193. doi: 10.1097/MD.0000000000003193.
9
Point-of-care ultrasonography improves the diagnosis of splenomegaly in hospitalized patients.床旁超声检查可改善住院患者脾肿大的诊断。
Crit Ultrasound J. 2015 Dec;7(1):13. doi: 10.1186/s13089-015-0030-8. Epub 2015 Sep 17.
10
Extrahepatic morbidity and mortality of chronic hepatitis C.慢性丙型肝炎的肝外发病率和死亡率。
Gastroenterology. 2015 Nov;149(6):1345-60. doi: 10.1053/j.gastro.2015.08.035. Epub 2015 Aug 28.